Abstract:The direct killing of cancer cells by cytotoxic T-lymphocytes (CTL) is critical for achieving effective antitumor immune responses. While several tumor-intrinsic mutations have been identified that promote evasion to CTL killing, there remains a paucity of data cataloging how individual genetic perturbations impact cancer cell fitness under immunotherapeutic selection pressure. Towards this, genetic screens using the CRISPR-Cas9 system have recently been employed, identifying novel intrinsic genetic regulators of cancer immunotherapy fitness. While these initial studies demonstrate the significant potential of unbiased genetic screens for discovery of novel immunotherapy targets, they have been limited in application to a small number of disease models. As such, the degree to which intrinsic genetic perturbations robustly modulate immunotherapy fitness across diverse cancer genotypes remains largely unexplored. To circumvent this knowledge gap, we performed genetic screens across a panel of commonly utilized syngeneic murine cancer cell lines to identify a core set of genes that render cancer cells more sensitive or resistant to CTL killing across diverse genetic backgrounds. An optimized genome-scale gRNA library targeting ~19,000 protein-coding genes in the murine genome (termed mTKO; mouse Toronto Knockout) was created in an analogous manner to our human library. Screens were performed in multiple murine cell lines engineered to express model tumor-associated antigens. Cells were propagated in the presence or absence of preactivated antigen-specific CTLs, and gRNA abundance was quantified by illumina sequencing to identify perturbed genes enriched or depleted in CTL treated versus untreated populations. These screens uncovered known genetic regulators of CTL killing including immune checkpoints (Cd274), antigen presentation machinery (B2m, Tap1/2) and interferon signaling components (Socs1, Jak1/2, Ifngr1/2), benchmarking the utility of this approach. Importantly, we leveraged this dataset to derive a core list of genes whose perturbation significantly modulates cancer-cell fitness to CTL killing across the majority of genotypes screened. Gene set enrichment analysis revealed critical roles for cytokine and TLR signaling, the NF-κB and MAPK pathways as well as the antiviral and antigen presentation machineries. As such, our dataset represents the first step towards a comprehensive understanding of the functional genomic landscape of CTL-mediated cytotoxicity. Citation Format: Keith Lawson, Xiaoyu Zhang, Cris Sousa, Rummy Akthar, Zi Fan, Eiru Kim, Medina Colic, Amy Tong, Katie Chan, Qian Huang, Xiaowei Wang, Kevin Brown, Michael Aregger, Antonio Finelli, Laurie Ailles, Traver Hart, Gillian Kingsbury, Charles Kung, Jason Moffat. Functional genomic landscape of T-cell mediated cytotoxicity [abstract]. In: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2018 Nov 27-30; Miami Beach, FL. Philadelphia (PA): AACR; Cancer Immunol Res 2020;8(4 Suppl):Abstract nr B60.

Germline mutations in a G protein identify signaling cross-talk in T cells

Two naturally occurring mutations of human GPR103 define distinct G protein selection bias

Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function

Visualizing the impact of disease-associated mutations on G protein–nucleotide interactions

Functional genomic landscape of T-cell mediated cytotoxicity.

Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated G{alpha} in Human Cancer

Sensitivity to Vγ9Vδ2TCR T cells is imprinted after single mutations during early oncogenesis

Identification of essential genes for cancer immunotherapy

α Regulates Biochemical Signaling in Neurons Associated with Movement Control and Initiation

3010 – MOLECULAR DETERMINANTS OF INNATE IMMUNE SIGNAL-DEPENDENT GENOME RESPONSIVENESS IN HEMATOPOIETIC PROGENITOR CELLS

Naturally occurring hotspot cancer mutations in Gα13 promote oncogenic signaling

Interaction networks within disease-associated GαS variants characterized by an integrative biophysical approach

From Mutations to Disease: Computational Analysis and Interpretation of GPCR-Associated Pathogenicity

A Genome-Wide Rnai Screen Reveals A Trio-Regulated Rho Gtpase Circuitry Transducing Mitogenic Signals Initiated by G Protein-Coupled Receptors

Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models

A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing GPCR-initiated mitogenic signals

Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis

Loss of Signalling Via Gα13 in Germinal Centre B-cell-derived Lymphoma

Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency

Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis